target is $2. Centene ( CNC +1.5% ) upgraded to Positive from Neutral at Susquehanna. Price target is $68. St . Jude Medical ( STJ +2.4% ) upgraded to Outperform from Market Perform at BMO. Price target is $66. Evogene ( EVGN -3.4
St . Jude Medical 's ( STJ ) board authorizes $700M in buybacks funded from cash on hand "as well as other sources of available liquidity." ( PR ) Post your comment!
St . Jude Medical , Inc. ( STJ ) declares $0.25/share quarterly dividend , in line with previous. Forward yield 1.69% Payable Jan 31; for shareholders of record Dec. 31; ex-div Dec. 27. Post your comment!
50 cents/share. The company's peer group includes Medtronic ( MDT ), Baxter International ( BAX ) and St . Jude Medical ( STJ ). Over the past decade, this dividend growth stock has delivered an annualized total return of 12.40% to
St . Jude Medical , Inc. ( STJ ) Piper Jaffray Healthcare Conference ..... pleased to have Don Zurbay, the CFO of St . Jude with us today, in addition to J ..... seekingalpha.com/article/1874101- st - jude -medicals-management-presents
think long term, their technology is good." St . Jude Medical ( STJ ): "When it comes to medical equipment, I only like St . Jude Medical ." Enterprise Products Partners ( EPD ): "A
Resources ( PXD ): "Emerald is okay. With Pioneer coming down, I'm more intrigued by Pioneer. That may be cheaper." St . Jude ( STJ ): "It got downgraded and no one cared. They just kept on buying." EOG Resources ( EOG ): Cramer prefers EOG to Chesapeake
Bernstein downgrades St . Jude Medical ( STJ -2.6% ) to Market Perform from Outperform. Analyst Derrick Sung still likes STJ 's position in the CRM market, but with the stock up 60% YTD
that was acquired by St . Jude in 1996. We think Starks ..... reasonable, and like that St . Jude aims to hit the 60th ..... medical device companies, St . Jude makes regular acquisitions ..... for its acquisitions. St . Jude Medical manufactures cardiovascular
St . Jude Medical released third-quarter performance ..... realized since our last update. While St . Jude continues to wrestle with a lackluster ..... change our stable moat trend rating. St . Jude saw its quarterly revenue rise 3% in